General Archive
-
ArticlesProud to be part of the scientific community driving MND research
The status of scientific understanding of MND and the ambition behind creating the joint fund with the MND Association
-
News releasesLifeArc publishes expert advice to support work around repurposing medicines
Guide will support researchers and charities who focus on diseases which have few effective therapies
-
News releasesPostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19
£100,000 grant to develop a globally-accessible, oral antiviral as part of the COVID Moonshot initiative
-
News releasesKQ Labs opens applications for health start-ups for its annual accelerator programme
This year’s programme delivered by the Francis Crick Institute and funded by LifeArc
-
News releasesAdvise & Connect: LifeArc offers expertise and funding to help tackle Covid-19
Access our advice, network and potentially more
-
News releasesLifeArc and the MND Association commit £1m to boost search for new treatments
Bolstered by the fundraising efforts of Leeds Rhinos’ coach, Kevin Sinfield
-
News releasesAction Medical Research and LifeArc announce joint funding awards for translational research into children’s rare diseases
Third joint funding round of up to £1 million
-
News releasesLifeArc invests in Cumulus Neuroscience
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
-
News releasesIndustry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care
London, UK: Novartis UK has launched the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs, the data-driven…
-
ArticlesRepurposing drugs: the opportunity and the challenges
Catriona Crombie outlines the case studies from our seminar on drug repurposing
-
News releasesLifeArc appoints Dr Linda Bradley to head up business development
Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.
-
News releasesLifeArc, MRC and BBSRC create £18m network of gene therapy hubs to advance promising research into new treatments for patients
Hubs will be at King’s College London, NHS Blood and Transplant in Bristol and the University of Sheffield